A Phase I Study of SNH-119014 in Healthy Volunteers

Clinical trial NCT07087262 · RECRUITING

Trial details

NCT number: NCT07087262
Sponsor: ScinnoHub Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hemoglobinopathy

Start date: 2025-06-27
Primary completion: 2026-03-28
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.